# Octapharma Plasma, Inc. – FDA Inspection, May 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/65b7ba4d-aa0b-45ba-bcd1-a5614d8f6a3a
Source feed: FDA_Inspections

> FDA inspection 1053924 of Octapharma Plasma, Inc., May 24, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 606 and 640. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053924
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2018-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1230736 - 2024-03-01
- [FDA Inspection 947463 - 2015-08-10](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/52d76d85-6aa1-4db6-8818-5bcdddc91758)
- FDA Inspection 824137 - 2013-03-21
- FDA Inspection 824403 - 2013-03-20

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/decarlos-a-gomez/4b003235-edbb-4cb5-acb1-4e154941578c)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/ff648f25-d2e8-49f9-a56a-e67f2f9030d7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d